Nanotechnology: Players, products & prospects to 2018 (Volume II) : Market Research Report

Nanotechnology: Players, products & prospects to 2018 (Volume II)

Published by: Espicom Healthcare Intelligence

Published: Jun. 26, 2009 - 106 Pages

EXECUTIVE SUMMARY
INTRODUCTION: Overview of nanotechnology: past, present & future; Multifunctional nanotechnology platform; Nanotechnology: motivators & resistors; Motivators; Nanotechnology motivators; Resistors; Nanotechnology resistors; Nanomedicines, formulations and product regeneration; Failure rates at each stage of clinical drug development
NANOTECHNOLOGY IN DRUG DELIVERY: Core nanotechnology used by the pharma industry; Nano-engineered drugs; Nano-carriers; Dendrimer structure; Liposome structure; Micelle structure; Polymeric nanoparticle structure - Abraxane; Current therapeutic applications of nanotechnology in drug delivery; Leading brands that utilise nanotechnology delivery; Nanotechnology-enabled approved drugs; Future commercial applications & opportunities
STRATEGIES OF DRUG DELIVERY COMPANIES: Leading nanotechnology drug delivery companies; Leading nanotechnology-enabled drug delivery companies; Partnerships & acquisitions; Strategic development & commercialisation partnerships and joint ventures; Mergers, acquisitions, start ups & spin offs; Recent partnerships & acquisitions in the nanotechnology field; Intellectual Property; Nanotechnology patents
THE NANOTECHNOLOGY MARKET: Now 2009; Leading approved nano-enabled product sales; Leading companies developing nano-enabled product sales; Future 2018; Novel nano-enabled product sales; Global nano-enabled product sales
COMPETITOR ANALYSIS: Movers & Shakers: Cutting edge or losing their grip; Movers & shakers in nanotechnology drug delivery systems
COMPANY PROFILES: Abraxis Bioscience (www.abraxisbio.com); Access Pharmaceuticals (www.accesspharma.com); AlphaRx Corporation (www.alpharx.com); ALZA Corporation (www.alza.com); Aphios Corporation (www.aphios.com); APR Applied Pharma Research (www.apr.com); BioSante Pharmaceuticals (www.biosantepharma.com); Calando Pharmaceuticals (www. calandopharma.com); Camurus AB (www.camurus.se); Cerulean Pharma Inc (www.ceruleanrx.com); CytImmune Sciences Inc (www.cytimmune.com); Elan Corporation (www.elan.com); Enzon Pharmaceuticals, Inc. (www.enzon.com); Gilead Sciences (www.gilead.com); Introgen Therapeutics (www.introgen.com); Mersana Therapeutics (www.mersana.com); Nano Interface Technology (www.nanointerfacetech.com); Nano S Biotechnology GmbH (www.nano-s.com); NanoBio Corporation (www.nanobio.com); NanoBioMagnetics (www.nanobmi.com); Nanobiotix (www.nanobiotix.com); NanoCarrier (www.nanocarrier.co.jp); Nanotechnology Victoria, Ltd (www.nanovic.com); NanoMaterials Technology (www.nanomt.com); Nanotherapeutics (www.nanotherapeutics.com); Novavax (www.novavax.com); SkyePharma (www.skyepharma.com); Spherics (www.spherics.com); Starpharma (www.starpharma.com)
APPENDIX 1: Global nanotechnology approved drugs sales 2008-2018
APPENDIX 2: Global nanotechnology developmental drugs sales 2008-2018
APPENDIX 3: Competitor Ratio Analysis Criteria; Key nanotechnology delivery companies by 2018
GLOSSARY
ACRONYMS
Bibliography
Endnotes

Abstract

This major strategic analysis provides a detailed insight into the current and future market for nano-enabled drug delivery technology.

Get Full Details About This Report >>

US: 800.298.5699

Int'l: +1.240.747.3093

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 250,000 market research reports, company profiles and country profiles from over 650 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.

Nanotechnology: Players, products & prospects to 2018 (Volume II)

Table of Contents

Abstract